The DNA methylation landscape of advanced prostate cancer

Journal: Nature Genetics

Published: 2020-07-13

DOI: 10.1038/s41588-020-0648-8

Affiliations: 54

Authors: 69

Go to article
Institutions Share
UCSF Helen Diller Family Comprehensive Cancer Center, United States of America (USA) 0.17
UCSF Department of Radiation Oncology, United States of America (USA) 0.11
UCSF Division of Hematology and Medical Oncology, United States of America (USA) 0.09
Illumina, Inc., United States of America (USA) 0.06
Vancouver Prostate Centre (VPC), Canada 0.05
UCSF Department of Neurological Surgery, United States of America (USA) 0.03
UCSF Department of Urology, United States of America (USA) 0.03
Michigan Center for Translational Pathology (MCTP), U-M, United States of America (USA) 0.02
OHSU Knight Cancer Institute (KCI), United States of America (USA) 0.02
Princess Margaret Cancer Centre, U of T, Canada 0.02
Ontario Institute for Cancer Research (OICR), Canada 0.02
Department of Radiation Oncology, U-M, United States of America (USA) 0.02
Alvin J. Siteman Cancer Center, WUSTL, United States of America (USA) 0.02
UC Davis Comprehensive Cancer Center, United States of America (USA) 0.01
Department of Medicine, UW-Madison, United States of America (USA) 0.01
Hormel Institute, United States of America (USA) 0.01
UCSF Department of Biochemistry and Biophysics, United States of America (USA) 0.01
Department of Cancer Biology, Penn, United States of America (USA) 0.01
Duke Department of Pathology, United States of America (USA) 0.01
Department of Pathology, Pitt, United States of America (USA) 0.01
UCLA Department of Microbiology, Immunology and Molecular Genetics (MIMG), United States of America (USA) 0.01
Department of Cancer Biology, TJU, United States of America (USA) 0.01
Department of Medical Biophysics, U of T, Canada 0.01
UCLA Department of Medicine, United States of America (USA) 0.01
UCLA Department of Urology, United States of America (USA) 0.01
UCLA Jonsson Comprehensive Cancer Center (JCCC), United States of America (USA) 0.01
Rogel Cancer Center, U-M, United States of America (USA) 0.01
John T. Milliken Department of Medicine, WUSTL, United States of America (USA) 0.01
McDonnell Genome Institute (MGI), WUSTL, United States of America (USA) 0.01
Department of Laboratory Medicine and Pathology (LMP), UMN, United States of America (USA) 0.01
Masonic Cancer Center, UMN, United States of America (USA) 0.01
Oncode Institute, Netherlands 0.01
Netherlands Cancer Institute (NKI), Netherlands 0.01
OHSU Department of Molecular and Medical Genetics (MMG), United States of America (USA) 0.01
UCSF Center for Advanced Technology (CAT), United States of America (USA) 0.01
UC Davis School of Medicine, United States of America (USA) 0.01
BC Cancer Agency (BCCA), PHSA, Canada 0.01
UC Davis Division of Hematology and Oncology, United States of America (USA) 0.01
Department of Surgery, WUSTL, United States of America (USA) 0.01
The University of Melbourne (UniMelb), Australia 0.01
Peter MacCallum Cancer Centre (Peter Mac), Australia 0.01
OHSU Division of Hematology and Medical Oncology, United States of America (USA) 0.01
OHSU Department of Pathology, United States of America (USA) 0.01
Department of Urology, U-M, United States of America (USA) 0.01
UCLA Department of Human Genetics, United States of America (USA) 0.01
UCLA Institute for Precision Health, United States of America (USA) 0.01
Yale School of Medicine (YSM), United States of America (USA) 0
UCSF Department of Epidemiology and Biostatistics, United States of America (USA) 0
UCSF Department of Anatomy, United States of America (USA) 0
VA Greater Los Angeles Healthcare System, United States of America (USA) 0
Department of Biomedical Engineering (BME), WUSTL, United States of America (USA) 0
Department of Pathology, U-M, United States of America (USA) 0
Department of Computational Medicine and Bioinformatics (DCM&B), U-M, United States of America (USA) 0
Medical School, U-M, United States of America (USA) 0

Return